| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.19B | 9.00B | 9.25B | 9.30B | 9.37B | 10.87B |
| Gross Profit | 2.79B | 2.63B | 2.92B | 3.35B | 3.02B | 3.79B |
| EBITDA | 2.47B | 4.39B | 4.05B | 5.55B | 4.75B | 5.22B |
| Net Income | 1.18B | 1.12B | 1.15B | 2.33B | 2.02B | 2.61B |
Balance Sheet | ||||||
| Total Assets | 70.73B | 71.47B | 67.56B | 67.51B | 69.20B | 60.61B |
| Cash, Cash Equivalents and Short-Term Investments | 7.99B | 8.18B | 3.04B | 2.62B | 4.75B | 4.41B |
| Total Debt | 35.93B | 36.43B | 26.70B | 27.88B | 31.17B | 20.71B |
| Total Liabilities | 42.28B | 43.18B | 40.36B | 39.51B | 41.84B | 32.84B |
| Stockholders Equity | 23.40B | 23.04B | 21.90B | 22.36B | 21.35B | 24.64B |
Cash Flow | ||||||
| Free Cash Flow | 2.68B | 2.01B | 1.66B | 2.00B | 1.28B | 143.13M |
| Operating Cash Flow | 5.21B | 5.20B | 3.72B | 4.09B | 3.37B | 3.94B |
| Investing Cash Flow | -4.55B | -5.39B | -36.15M | -923.61M | -3.44B | -5.13B |
| Financing Cash Flow | -3.45B | 2.22B | -2.81B | -4.41B | -2.34B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$66.82B | 8.26 | 11.50% | 5.43% | -16.77% | -1.46% | |
69 Neutral | HK$30.85B | 10.40 | 14.74% | 5.08% | -5.31% | 10.69% | |
65 Neutral | HK$3.21B | 6.01 | 10.60% | 5.25% | 1.17% | -0.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$21.24B | 8.52 | 7.54% | 5.82% | -16.28% | -1.83% | |
60 Neutral | HK$3.60B | 4.38 | 6.26% | 6.05% | -66.15% | -21.01% | |
55 Neutral | HK$23.36B | 8.30 | 4.88% | 3.72% | 4.71% | -4.62% |